Gilead Taps New Talent In China Hepatitis Drug Access Drive
In signs of a strategy shift, Gilead Sciences appears to be independently pursuing opportunities in China's rapidly growing hepatitis market by appointing a top market access executive.
In signs of a strategy shift, Gilead Sciences appears to be independently pursuing opportunities in China's rapidly growing hepatitis market by appointing a top market access executive.